81. HPA - Infections | Respiratory Syncytial Virus respiratory syncytial virus (RSV) causes respiratory infection. It is the commonest cause of severe respiratory illness such as bronchiolitis (inflammation http://www.hpa.org.uk/infections/topics_az/rsv/menu.htm

Skip navigation menu Search Advanced Search Home About Us Topics A-Z ... Contact Us Infectious Diseases Infections A-Z list HPA Centre for Infections Services and Activities Bioinformatics ... STBRL Key Functions Infectious Diseases Radiation Emergency Response Business Activities Respiratory Syncytial Virus (RSV) Respiratory Syncytial Virus (RSV) causes respiratory infection. It is the commonest cause of severe respiratory illness such as bronchiolitis (inflammation of the bronchioles) in young children (aged under 2 years), and it is the commonest cause of hospital admissions due to acute respiratory illness in young children. RSV infections may be overlooked in older children and adults. Several studies have shown that RSV causes severe respiratory illness in elderly people and that outbreaks are associated with higher death rates. Peak numbers of RSV infections are reported in December and January every winter, although the size of the peak varies from winter to winter. Menu General information Epidemiological data Guidelines Publications ... Back © Health Protection Agency Home Search Contact Us Accessibility ... Freedom of Information Search powered by

82. Respiratory Syncytial Virus (RSV) Fact Sheet The major responsibilities of the Communicable Disease Control Program are to identify disease outbreaks, respond rapidly to suspect and confirmed diseases http://health.utah.gov/els/epidemiology/epifacts/rsv.html

DELS Home Page Communicable Disease Control Epidemiology Communicable Disease ... Utah Public Health Lab Respiratory Syncytial Virus (Viral Respiratory Disease, RSV) (*PDF version) for printing. What is respiratory syncytial virus? Respiratory syncytial virus (RSV) is a viral disease of the respiratory tract that occurs primarily during the winter and early spring. Who gets RSV? RSV is very common; almost everyone has an infection with this virus in their first few years of life. RSV is a cause of the common cold in persons of most ages. However, in infants and young children, it is the most important cause of inflammation of the bronchial tubes of the lungs and of pneumonia. For children under six months of age it can be a severe disease, especially if they have a condition such as prematurity, heart disease at birth, respiratory disease, or a disease or treatment affecting the immune system. How is the virus spread?

83. Respiratory Syncytial Virus respiratory syncytial virus (RSV) is a common cause of many types of infections of the respiratory system (lungs and breathing passages), including http://healthgate.partners.org/browsing/browseContent.asp?fileName=1543.xml&titl

84. Medco Specialty Solutions; The Medco Special Care Pharmacy About respiratory syncytial virus (RSV). This class of specialty drugs affects conditions associated with the lungs. http://www.medco.com/medco/corporate/home.jsp?ltSess=y&articleID=SpecialtyCOERsv

85. Respiratory Syncytial Virus (RSV), Cincinnati Children's Hospital Medical Center respiratory syncytial virus (RSV) symptoms, diagnosis, transmission and treatment information, provided by Cincinnati Children s Hospital Medical Center. http://www.cincinnatichildrens.org/health/infection/rsv.htm

Home Contact Us Site Map Go to Advanced Search ... Flu Respiratory Syncytial Virus (RSV) Infection Control Matters Respiratory Syncytial Virus (RSV) Related Services Infectious Diseases General and Community Pediatrics What is RSV? How is RSV transmitted? ... Additional information What is respiratory syncytial virus (RSV)? Respiratory syncytial virus (RSV) is a viral organism that can cause upper and lower respiratory tract infections. It most commonly causes bronchiolitis (inflammation of the lower airways) and pneumonia in children and infants under the age of 1. In the United States, RSV is more common during the winter and spring months. For most children and infants, RSV is a virus that can be managed on an outpatient basis. However, about 0.5 to 2% of children and infants who develop RSV may require hospitalization. The disease usually runs its course in one to two weeks. Children who are at risk for developing more severe cases or RSV include the following: Children / infants younger than 1 year, particularly those between 6 weeks and 6 months Premature infants Children / infants with breathing or heart problems Children / infants with weakened immune systems Return to Top How is RSV transmitted?

86. Respiratory Research | Full Text | Immunoprophylaxis Of Respiratory Syncytial Vi Immunoprophylaxis of respiratory syncytial virus global experience The link between respiratory syncytial virus and reactive airway disease http://respiratory-research.com/content/3/S1/S26

Home Browse articles Supplements Search ... Suppl 1 Viewing options Abstract Full text PDF Associated material: PubMed record Related literature: Articles citing this article on Google Scholar on ISI Web of Science Other articles by authors ... Similar articles (PubMed) Tools: E-mail to a friend Download references Post a comment Key E-mail Corresponding author Supplement Immunoprophylaxis of respiratory syncytial virus: global experience Eric AF Simoes Department of Pediatrics, Section of Infectious Diseases, The University of Colorado School of Medicine and The Children's Hospital, Denver, Colorado, USA RSV and RAD: possibilities for prevention? The link between respiratory syncytial virus and reactive airway disease Sitges, Spain. 21 March 2002 Respiratory Research (Suppl 1) The electronic version of this article is the complete one and can be found online at: http://respiratory-research.com/content/3/S1/S26 Received Accepted Published Keywords: monoclonal antibody, palivizumab, passive immunity, respiratory syncytial virus, Synagis Abstract Respiratory syncytial virus (RSV) infects nearly all children by age 2 years, and it causes considerable illness and death in certain high-risk pediatric populations. Historically, treatment for RSV has been symptomatic, and developing a safe and effective vaccine has been a challenge. Therefore, research efforts have turned to passive immunization as the best option to control RSV. Palivizumab, a genetically engineered humanized monoclonal antibody, has been shown to reduce RSV-related hospitalizations significantly, with few adverse effects. It was approved for use in high-risk children in the USA in 1998 and in Europe in 1999; it is now approved for use in more than 45 countries. The efficacy and safety of palivizumab continue to be supported by both clinical trial and outcomes data.

87. Respiratory Research | Full Text | Pathophysiological Mechanisms For The Respira The link between respiratory syncytial virus and reactive airway disease respiratory syncytial virus (RSV) is the most important respiratory pathogen in http://respiratory-research.com/content/3/S1/S21

Home Browse articles Supplements Search ... Suppl 1 Viewing options Abstract Full text PDF Associated material: PubMed record Related literature: Articles citing this article on Google Scholar on ISI Web of Science Other articles by authors ... Similar articles (PubMed) Tools: E-mail to a friend Download references Post a comment Key E-mail Corresponding author Supplement Pathophysiological mechanisms for the respiratory syncytial virus-reactive airway disease link Giovanni Piedimonte Departments of Pediatrics, Medicine, and Molecular/Cellular Pharmacology, University of Miami School of Medicine, Miami, Florida, USA RSV and RAD: possibilities for prevention? The link between respiratory syncytial virus and reactive airway disease Sitges, Spain. 21 March 2002 Respiratory Research (Suppl 1) The electronic version of this article is the complete one and can be found online at: http://respiratory-research.com/content/3/S1/S21 Received Accepted Published Keywords: asthma, palivizumab, pediatrics, prevention, reactive airway disease, respiratory syncytial virus Outline Abstract Abstract Introduction RSV LRTI: epidemiology and long-term consequences Cellular and molecular mechanisms linking RSV to RAD ... References Introduction Respiratory syncytial virus (RSV) is the most important respiratory pathogen in infancy and can cause serious lower respiratory tract infections (LRTIs), particularly in prematurely born infants and children with underlying cardiorespiratory conditions

88. Children's Hospital What are the symptoms of respiratory syncytial virus (RSV)? The following are the most common symptoms of RSV. However, each baby may experience symptoms http://www.childrenscentralcal.org/content.asp?id=1743&parent=1&groupid=G0057

89. Respiratory Syncytial Virus (RSV) Infection 480.1 Pneumonia due to respiratory syncytial virus SEE ALSO. Bronchiolitis Pneumonia, bacterial Pneumonia, viral Bronchitis, acute. REFERENCES http://www.5mcc.com/Assets/SUMMARY/TP0792.html

Respiratory syncytial virus (RSV) infection DESCRIPTION: RSV causes respiratory illness Adults: URI's Infants and children: bronchitis, bronchiolitis, pneumonia Leading cause of pediatric admissions for respiratory illness System(s) affected: Pulmonary Genetics: None known Incidence/Prevalence in USA: Common in winter. Almost all persons infected one or more times during lifetime. Predominant age: Birth to age 2 Predominant sex: Males = females as outpatients 2:1 males/females in hospital CAUSES: Infection with RSV ICD-9-CM: 480.1 Pneumonia due to respiratory syncytial virus SEE ALSO: Bronchiolitis Pneumonia, bacterial Pneumonia, viral Bronchitis, acute REFERENCES: Mandell GL, ed: Principles and Practice of Infectious Diseases. 4th Ed. New York, Churchill Livingstone, 1995 Gilchrist S, et al: National surveillance for RSV, U.S., 1985-1990. J Inf Dis 1994;170:986-990 Groothuis J, et al: Prophylactic administration of RSV immune globulin to high risk infants and young children. New Engl J Med 1993;329:1524-1530 Author(s): Joseph G. Ewing, MD

90. Caremark.com RSV stands for respiratory syncytial virus, a major cause of respiratory illness The respiratory syncytial virus is present for about six months of the http://www.caremark.com/wps/portal/_s.155/3338/.cmd/ad/.pm/-/.c/867/.ce/3134/.p/

91. Ribavirin For Respiratory Syncytial Virus Infection Of The Lower Respiratory Tra Abstract of a systematic review of the effects of health care prepared by the Cochrane Collaboration. http://www.update-software.com/Abstracts/AB000181.htm

From The Cochrane Library, Issue 3, 2005 Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children (Cochrane Review) Ventre K, Randolph AG ABSTRACT What's new in this issue Search abstracts Browse alphabetical list of titles Browse by Review Group A substantive amendment to this systematic review was last made on 25 August 2004. Cochrane reviews are regularly checked and updated if necessary. Background: Respiratory syncytial virus (RSV) is a common cause of lower respiratory tract infection in infants and is responsible for 100,000 hospitalizations annually. Ribavirin is approved for treatment of these infections, but its use is controversial because of questions about its efficacy, concerns about occupational exposure, and its high cost. Objectives: The objective of this review is to assess the efficacy of aerosolized ribavirin for infants and children with lower respiratory tract infection due to RSV. Search strategy: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, Issue 1, 2004), MEDLINE (January 1975 to January week 3, 2004) and EMBASE (January 1990 to December 2003). We scanned reference lists of articles and contacted experts in the field.

92. FIRSTConsult - Sdfdsf FIRSTConsult, respiratory syncytial virus infection (Patient Education File). Published for medical students and primary healthcare providers by Elsevier. http://www.firstconsult.com/?action=view_article&id=1037505&type=103&bref=1

93. FIRSTConsult - Sdfdsf FIRSTConsult, respiratory syncytial virus infection (Medical Condition File). Published for medical students and primary healthcare providers by Elsevier. http://www.firstconsult.com/?action=view_article&id=1014295&type=101&bref=1

94. Pharmaceutical Research And Manufacturers Of America none / respiatoy syncytial virus vaccine. respiratory syncytial virus (RSV) MedImmune Gaithersburg, MD. Phase I. RSV vaccine none / none http://www.phrma.org/newmedicines/newmedsdb/drugs.cfm?indicationcode=Respiratory

95. BioMed Central | Full Text | Hospitalisations For Respiratory Syncytial Virus Br Hospitalisations for respiratory syncytial virus bronchiolitis in Akershus, Respiratory tract infections due to respiratory syncytial virus (RSV) are http://www.biomedcentral.com/1471-2431/4/25

home journals A-Z subject areas advanced search ... Volume 4 Viewing options Abstract Full text PDF Associated material: Pre-publication history PubMed record Related literature: Articles citing this article on BioMed Central on Google Scholar Other articles by authors ... Similar articles (PubMed) Tools: E-mail to a friend Download references Post a comment Key E-mail Corresponding author Research article Hans-Olav Fjaerli Teresa Farstad and Dag Bratlid University of Oslo, Faculty Division Akershus University Hospital, 1474 Nordbyhagen, Norway Department of Paediatrics, Akershus University Hospital, 1474 Nordbyhagen, Norway Department of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology; Department of Paediatrics, St. Olav University Hospital, Trondheim, Norway BMC Pediatrics The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-2431/4/25 Received Accepted Published This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0

96. BioMed Central | Full Text | Defining The Timing Of Respiratory Syncytial Virus respiratory syncytial virus (RSV) is the most common cause of viral bronchiolitis Waris M Pattern of respiratory syncytial virus epidemics in Finland http://www.biomedcentral.com/1471-2334/5/20

home journals A-Z subject areas advanced search ... Volume 5 Viewing options Abstract Full text PDF Associated material: Pre-publication history PubMed record Related literature: Articles citing this article on Google Scholar on ISI Web of Science Other articles by authors ... Similar articles (PubMed) Tools: E-mail to a friend Download references Post a comment Key E-mail Corresponding author Research article Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study Elena Terletskaia-Ladwig Gisela Enders Gunnar Schalasta and Martin Enders BMC Infectious Diseases The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-2334/5/20 Received Accepted Published This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Outline Abstract Abstract Background Methods Results ... Pre-publication history Background Seasonal RSV infections occur every year and affect particularly children under six months of age. Passive immunoprophylaxis with monoclonal antibody Palivizumab is recommended in the period with high risk of RSV infection. This study aims to define the period for the southern part of Germany (Stuttgart area).

97. Respiratory Syncytial Virus (RSV) By Immunoassay Severe lifethreatening infections due to respiratory syncytial virus can occur during Kim HW, Wyatt RG, Fernie BF, et al, respiratory syncytial virus http://www.labcorp.com/datasets/labcorp/html/chapter/mono/mb011300.htm

Respiratory Syncytial Virus (RSV) by Immunoassay Number CPT Related Information Viral Culture, General Viral Culture, Rapid, Respiratory Virus, Direct Detection by DFA, Adenovirus Virus, Direct Detection by DFA, Herpes Simplex Virus Synonyms RSV by EIA; RSV Testing Special Instructions Submit one specimen per test requested. Specify the exact specimen source/origin (eg, nasopharyngeal aspirate). Indicate a specific test number on the request form. Specimen Nasopharyngeal washes or aspirates (preferred), nasopharyngeal swabs; refrigerated or frozen Volume Washes 2-3 mL; aspirates 0.5-1.0 mL Container Sterile leakproof container for washes or aspirates; viral transport media for swabs Collection Nasopharyngeal wash or aspirate using routine collection and transport procedure. Nasal swabs are not considered as sensitive for RSV detection. Avoid using collection containers with preservatives or transport that may contain interfering substances. Do not use calcuim alginate swabs. Obtain sample during acute phase of illness when greatest amount of viral shedding occurs. To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit separate frozen specimens for each test requested. Storage Instructions Refrigerated up to 72 hours

98. Health Updates Bovine respiratory syncytial virus (BRSV) and Parainfluenza3 EJ Richey University of Florida, Institute of Food and Agricultural Sciences (UF/IFAS) - http://www.mycattle.com/health/updates/dsp_update.cfm?ID=17385&s=4

99. Respiratory Syncytial Virus - YourDictionary.com - American Heritage Dictionary Search Mamma.com for respiratory syncytial virus respiratory syncytial virus n. Abbr. RSV. An RNAcontaining virus that causes minor respiratory http://www.yourdictionary.com/ahd/r/r0181775.html

Search Mamma.com for "respiratory syncytial virus" Search: Normal Definitions Short defs (Pronunciation Key) respiratory syncytial virus n. Abbr. RSV An RNA-containing virus that causes minor respiratory infections in adults and bronchitis and bronchopneumonia in children. Back to Search Back The American Heritage Dictionary of the English Language, Fourth Edition

100. UpToDate Respiratory Syncytial Virus INTRODUCTION — respiratory syncytial virus (RSV) causes acute respiratory tract illness in persons of all ages. Almost all children are affected by two http://patients.uptodate.com/topic.asp?file=pedi_id/20617

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 5     81-100 of 107    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20